Specto Design is a high-end 
“New infectious agents originate all the time dating back to the plague in the siege of Athens in the 7th Century to the endemic flu in 1918 that killed 20 million people. For medical science, it’s a perennial race between new infectious diseases coming up and society reacting to them, understanding them and ultimately defeating them.” – Alessandro Sette, Ph.D.
Dr. Sette started at LIAI in 2002 as the Head of the Initiative for
Emerging Diseases and Biodefense. In 2003 he became the Head of the
Division of Translational Immunology. At LIAI, Dr. Sette's research
focuses on the identification of epitopes, working to understand how
vaccines should be constructed. The team's work is heavily focused on
emerging disease threats or bioterror threats, such as SARS, arena
viruses, smallpox and flu viruses. Dr. Sette's group is also leading an
effort to bring a premier collaboration resource to the scientific
community. The NIAID has awarded Dr. Sette a long-term contract to
design and produce a national Immune Epitope Database (IEDB) to aide in
the acceleration of vaccine-development on a global scale.
Dr. Sette received his degree in Biological Sciences from the University of Roma, Laboratory of Pathology in 1984. In 1984, Dr. Sette was a Postdoctoral Fellow in the same laboratory. From 1986-1988, he joined The National Jewish Center for Immunology and Respiratory Medicine in Denver, in the USA as a post-doctoral fellow.
In 2002, Dr. Sette was named Adjunct Professor in the Department of Experimental Medicine at the Scripps Research Institute, where he is also Scientific Director of the Rheumatic Diseases Core Center since 2004. In 2003 he was named Adjunct Professor in the department of Medicine at the University of California, San Diego.
Dr. Sette is a member of numerous grant review panels and a reviewer for many scientific publications. He is also a member of the editorial advisory board for Immunogenetics, Human Immunology, Current Pharmaceutical Biotechnology, Current Drugs, and Tissue Antigens.
Alessandro Sette, Dr. Biol.Sc., and his laboratory study ways to fight
diseases by understanding the immune response, measuring immune
activity, and developing disease intervention strategies against a
number of new and emerging infectious diseases. These include
Influenza, arena viruses, a family of viruses responsible for
hemorrhagic fever and meningitis, Severe Acute Respiratory Syndrome
(SARS) as well as diseases of renewed interest, such as smallpox,
because of the growing threat of bioterrorism. The laboratory is
defining in chemical terms what murine, non-human primate and human
immune system recognizes and uses this knowledge to measure and
understand anti-pathogen immune responses. This approach is helping
unlock the mysteries of how the body successfully battles infection,
and conversely, how pathogens escape the immune system, causing the
individual to succumb to disease. From this data, Sette and his team
believe their research will lead to development of new therapeutic and
prophylactic approaches to fighting infectious diseases.
Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage. 
